Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS

Clinical trial NCT03221621 · UNKNOWN

Trial details

NCT number: NCT03221621
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hidradenitis Suppurativa

Start date: 2018-07-31
Primary completion: 2022-07-31
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.